This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Mar;15(3):254-5.

doi: 10.1016/S1470-2045(14)70009-9. Epub 2014 Feb 10.

Subcutaneous rituximab: a practical approach?

Kensei Tobinai¹

Affiliations

PMID: 24521992
DOI: 10.1016/S1470-2045(14)70009-9

Comment

Subcutaneous rituximab: a practical approach?

Kensei Tobinai. Lancet Oncol. 2014 Mar.

. 2014 Mar;15(3):254-5.

doi: 10.1016/S1470-2045(14)70009-9. Epub 2014 Feb 10.

Author

Kensei Tobinai¹

Affiliation

¹ Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. Electronic address: ktobinai@ncc.go.jp.

PMID: 24521992
DOI: 10.1016/S1470-2045(14)70009-9

No abstract available

PubMed Disclaimer

Comment on

Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study.
Davies A, Merli F, Mihaljevic B, Siritanaratkul N, Solal-Céligny P, Barrett M, Berge C, Bittner B, Boehnke A, McIntyre C, Macdonald D. Davies A, et al. Lancet Oncol. 2014 Mar;15(3):343-52. doi: 10.1016/S1470-2045(14)70005-1. Epub 2014 Feb 10. Lancet Oncol. 2014. PMID: 24521993 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations